Related references
Note: Only part of the references are listed.Roles of VRK1 as a new player in the control of biological processes required for cell division
Alberto Valbuena et al.
CELLULAR SIGNALLING (2011)
Insights into protein kinase regulation and inhibition by large scale structural comparison
Jeyanthy Eswaran et al.
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2010)
RG7204 (PLX4032), a Selective BRAFV600E Inhibitor, Displays Potent Antitumor Activity in Preclinical Melanoma Models
Hong Yang et al.
CANCER RESEARCH (2010)
Mechanism of Radiosensitization by the Chk1/2 Inhibitor AZD7762 Involves Abrogation of the G2 Checkpoint and Inhibition of Homologous Recombinational DNA Repair
Meredith A. Morgan et al.
CANCER RESEARCH (2010)
In vitro and In vivo Radiation Sensitization of Human Tumor Cells by a Novel Checkpoint Kinase Inhibitor, AZD7762
James B. Mitchell et al.
CLINICAL CANCER RESEARCH (2010)
VRK2 Inhibits Mitogen-Activated Protein Kinase Signaling and Inversely Correlates with ErbB2 in Human Breast Cancer
Isabel F. Fernandez et al.
MOLECULAR AND CELLULAR BIOLOGY (2010)
Phenotypic profiling of the human genome by time-lapse microscopy reveals cell division genes
Beate Neumann et al.
NATURE (2010)
Analysis of Kinase Gene Expression Patterns across 5681 Human Tissue Samples Reveals Functional Genomic Taxonomy of the Kinome
Sami Kilpinen et al.
PLOS ONE (2010)
The Isoforms of the p53 Protein
Marie P. Khoury et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2010)
Targeting the cancer kinome through polypharmacology
Zachary A. Knight et al.
NATURE REVIEWS CANCER (2010)
Credentialing a Preclinical Mouse Model of Alveolar Rhabdomyosarcoma
Koichi Nishijo et al.
CANCER RESEARCH (2009)
Advances in the Development of Kinase Inhibitor Therapeutics for Alzheimer's Disease
Mary J. Savage et al.
DRUG DEVELOPMENT RESEARCH (2009)
Cell Signaling in Space and Time: Where Proteins Come Together and When They're Apart
John D. Scott et al.
SCIENCE (2009)
Protein Kinase Activation Loop Autophosphorylation in Cis: Overcoming a Catch-22 Situation
Pamela A. Lochhead
SCIENCE SIGNALING (2009)
Structure of the Pseudokinase VRK3 Reveals a Degraded Catalytic Site, a Highly Conserved Kinase Fold, and a Putative Regulatory Binding Site
Eric D. Scheeff et al.
STRUCTURE (2009)
Targeting cancer with small molecule kinase inhibitors
Jianming Zhang et al.
NATURE REVIEWS CANCER (2009)
Sixteen-kinase gene expression identifies luminal breast cancers with poor prognosis
Pascal Finetti et al.
CANCER RESEARCH (2008)
Aurora kinases as anticancer drug targets
Oliver Gautschi et al.
CLINICAL CANCER RESEARCH (2008)
VRK1 phosphorylates CREB and mediates CCND1 expression
Tae-Hong Kang et al.
JOURNAL OF CELL SCIENCE (2008)
Proteomics Identification of Nuclear Ran GTPase as an Inhibitor of Human VRK1 and VRK2 (Vaccinia-related Kinase) Activities
Marta Sanz-Garcia et al.
MOLECULAR & CELLULAR PROTEOMICS (2008)
AZD7762, a novel checkpoint kinase inhibitor, drives checkpoint abrogation and potentiates DNA-targeted therapies
Sonya D. Zabludoff et al.
MOLECULAR CANCER THERAPEUTICS (2008)
A quantitative analysis of kinase inhibitor selectivity
Mazen W. Karaman et al.
NATURE BIOTECHNOLOGY (2008)
Human VRK1 Is an Early Response Gene and Its Loss Causes a Block in Cell Cycle Progression
Alberto Valbuena et al.
PLOS ONE (2008)
Modulation of Interleukin-1 Transcriptional Response by the Interaction between VRK2 and the JIP1 Scaffold Protein
Sandra Blanco et al.
PLOS ONE (2008)
Prognostic Breast Cancer Signature Identified from 3D Culture Model Accurately Predicts Clinical Outcome across Independent Datasets
Katherine J. Martin et al.
PLOS ONE (2008)
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases
Oleg Fedorov et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
The selectivity of protein kinase inhibitors: a further update
Jenny Bain et al.
BIOCHEMICAL JOURNAL (2007)
Alteration of the VRK1-p53 autoregulatory loop in human lung carcinomas
Alberto Valbuena et al.
LUNG CANCER (2007)
Mitotic histone H3 phosphorylation by vaccinia-related kinase 1 in mammalian cells
Tae-Hong Kang et al.
MOLECULAR AND CELLULAR BIOLOGY (2007)
Vaccinia-related kinase 2 modulates the stress response to hypoxia mediated by TAK1
Sandra Blanco et al.
MOLECULAR AND CELLULAR BIOLOGY (2007)
Identification of a dominant epitope in human vaccinia-related kinase 1 (VRK1) and detection of different intracellular subpopulations
Alberto Valbuena et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2007)
Caenorhabditis elegans BAF-1 and its kinase VRK-1 participate directly in post-mitotic nuclear envelope assembly
Matyas Gorjanacz et al.
EMBO JOURNAL (2007)
Gene expression signature in organized and growth-arrested mammary acini predicts good outcome in breast cancer
Marcia V. Fournier et al.
CANCER RESEARCH (2006)
The subcellular localization of vaccinia-related kinase-2 (VRK2) isoforms determines their different effect on p53 stability in tumour cell lines
Sandra Blanco et al.
FEBS JOURNAL (2006)
Inhibition of casein kinase I delta alters mitotic spindle formation and induces apoptosis in trophoblast cells
M Stöter et al.
ONCOGENE (2005)
Sensitized RNAi screen of human kinases and phosphatases identifies new regulators of apoptosis and chemoresistance
JP MacKeigan et al.
NATURE CELL BIOLOGY (2005)
Nucleosomal histone kinase-1 phosphorylates H2A Thr 119 during mitosis in the early Drosophila embryo
H Aihara et al.
GENES & DEVELOPMENT (2004)
Characterization of three paralogous members of the mammalian vaccinia related kinase family
RJ Nichols et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
p53 stabilization and accumulation induced by human vaccinia-related kinase 1
FM Vega et al.
MOLECULAR AND CELLULAR BIOLOGY (2004)
c-Jun phosphorylation by the human vaccinia-related kinase 1 (VRK1) and its cooperation with the N-terminal kinase of c-Jun (JNK)
A Sevilla et al.
ONCOGENE (2004)
Human vaccinia-related kinase 1 (VRK1) activates the ATF2 transcriptional activity by novel phosphorylation on Thr-73 and Ser-62 and cooperates with JNK
A Sevilla et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
The vaccinia virus B1R kinase induces p53 downregulation by an Mdm2-dependent mechanism
CR Santos et al.
VIROLOGY (2004)
The specificities of protein kinase inhibitors: an update
J Bain et al.
BIOCHEMICAL JOURNAL (2003)
The protein kinase complement of the human genome
G Manning et al.
SCIENCE (2002)
First non-ATP competitive glycogen synthase kinase 3 β (GSK-3β) inhibitors:: Thiadiazolidinones (TDZD) as potential drugs for the treatment of Alzheimer's disease
A Martinez et al.
JOURNAL OF MEDICINAL CHEMISTRY (2002)
IC261, a specific inhibitor of the protein kinases casein kinase 1-delta and -epsilon, triggers the mitotic checkpoint and induces p53-dependent postmitotic effects
L Behrend et al.
ONCOGENE (2000)
The human vaccinia-related kinase 1 (VRK1) phosphorylates threonine-18 within the mdm-2 binding site of the p53 tumour suppressor protein
S Lopez-Borges et al.
ONCOGENE (2000)
The staurosporine analog, Ro-31-8220, induces apoptosis independently of its ability to inhibit protein kinase C
Z Han et al.
CELL DEATH AND DIFFERENTIATION (2000)